Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 16788-57-1
2. Potassium Phosphate Dibasic Trihydrate
3. Di-potassium Hydrogen Phosphate Trihydrate
4. Potassium Hydrogenphosphate Trihydrate
5. Phosphoric Acid, Dipotassium Salt, Trihydrate
6. Potassium Phosphate, Dibasic, Trihydrate
7. Dipotassium Phosphate Trihydrate
8. Dipotassium Monophosphate Trihydrate
9. Dipotassium Orthophosphate, Trihydrate
10. Dipotassium;hydrogen Phosphate;trihydrate
11. Rjk174x3tz
12. Dipotassium Hydrogen Phosphate, Trihydrate
13. Dipotassium Hydrogen Phosphate (k2hpo4) Trihydrate
14. Phosphoric Acid, Dipotassium Salt, Trihydrate (8ci,9ci)
15. Potassium Hydrogen Phosphate Trihydrate
16. Mfcd00149926
17. Unii-rjk174x3tz
18. Dtxsid60168418
19. Trihydratedibasicpotassium Phosphate
20. Bcp21720
21. Akos015914013
22. Akos015950675
23. Potassium Hydrogen Phosphate, Trihydrate
24. Ft-0625293
25. Di-potassium Hydrogen Orthophosphate 3-hydrate
26. Potassium Hydrogen Phosphate Trihydrate, Reagent Grade
27. Q27288149
Molecular Weight | 228.22 g/mol |
---|---|
Molecular Formula | H7K2O7P |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 0 |
Exact Mass | 227.9203525 g/mol |
Monoisotopic Mass | 227.9203525 g/mol |
Topological Polar Surface Area | 86.4 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 46.5 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 6 |
ABOUT THIS PAGE
A Potassium phosphate dibasic trihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Potassium phosphate dibasic trihydrate, including repackagers and relabelers. The FDA regulates Potassium phosphate dibasic trihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Potassium phosphate dibasic trihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Potassium phosphate dibasic trihydrate supplier is an individual or a company that provides Potassium phosphate dibasic trihydrate active pharmaceutical ingredient (API) or Potassium phosphate dibasic trihydrate finished formulations upon request. The Potassium phosphate dibasic trihydrate suppliers may include Potassium phosphate dibasic trihydrate API manufacturers, exporters, distributors and traders.
Potassium phosphate dibasic trihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Potassium phosphate dibasic trihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Potassium phosphate dibasic trihydrate GMP manufacturer or Potassium phosphate dibasic trihydrate GMP API supplier for your needs.
A Potassium phosphate dibasic trihydrate CoA (Certificate of Analysis) is a formal document that attests to Potassium phosphate dibasic trihydrate's compliance with Potassium phosphate dibasic trihydrate specifications and serves as a tool for batch-level quality control.
Potassium phosphate dibasic trihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Potassium phosphate dibasic trihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Potassium phosphate dibasic trihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Potassium phosphate dibasic trihydrate EP), Potassium phosphate dibasic trihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Potassium phosphate dibasic trihydrate USP).
LOOKING FOR A SUPPLIER?